At present, 4 pharmaceutical companies announced the successful synthesis of imitation Remdesivir in Taiwan

Comprehensive Yuxuan At present, there are four enterprises in China, including Borui pharmaceutical, Kelun pharmaceutical, Keben pharmaceutical and Hainan Haiyao, guanxuan is imitating radcivir On the 21st, it took 14 days for Taiwan's "China Academy of Sciences" to successfully synthesize Ridgeway At present, there are four enterprises in China, including Borui pharmaceutical, Kelun pharmaceutical, Keben pharmaceutical and Hainan Haiyao, guanxuan is imitating radcivir On February 11, Borui pharmaceutical announced that it has successfully copied and developed the synthesis process technology and preparation technology of radcivir APIs, and the company has mass produced radcivir APIs Up to now, the cost of Borui pharmaceutical in the development and production of raw materials and preparations of radcivir is estimated to be about 5 million yuan, and in the later stage of scale-up production, it is estimated that about 10 million yuan needs to be invested CUHK also pointed out on February 13 that Keben pharmaceutical, a holding subsidiary, is also developing the generic antiviral drug radcivir On the same day, Kelun pharmaceutical said on the interactive platform that on the day when the literature disclosed that radcivir has potential anti crown effect, the Research Institute of Kelun pharmaceutical set up the project and immediately started relevant research work On February 14, Hainan Haiyao also announced that it has completed the R & D of raw materials and preparation process of radcivir, and has carried out pilot production of radcivir preparation At present, the company has the capacity of mass production of 50 mg and 100 mg of radcivir, with an annual production capacity of 3.5 million On February 17, Kelun pharmaceutical announced that since the establishment of the research team on January 21, the company has made every effort to promote the research of one innovative polypeptide drug and three generic drugs covering prevention and treatment Among them, Cologne pharmaceutical only disclosed the information of two generic drugs, i.e lopinavir / ritonavir tablets and oseltamivir capsules For the third generic drug without a published name, the relevant person in charge of the company later mentioned in an interview with the cover news media that it was readcivir Small test sample of redcivir in Kelun Pharmaceutical Co., Ltd In February 21st, novel coronavirus pneumonia was also announced in Taiwan, according to Phoenix Satellite TV Reed has also synthesized a new drug called "cwest Wei" for the treatment of new crown pneumonia Liang Genyi, Taiwan's "director of health research", said that it took only 14 days to complete the synthesis of ridcivir at the milligram level, with a purity of 97% It is expected to be upgraded to the gram level within two weeks In the future, it can meet the needs of the outbreak, but it is hoped that it will be "prepared but not used" On February 21, at a press conference held by the State Council on the joint prevention and control mechanism of the new crown epidemic, Xu Nanping, Vice Minister of the Ministry of science and technology, said that radcivir is conducting relatively large-scale clinical trials in 10 hospitals in Wuhan, and has enrolled more than 200 severe and critical patients and more than 30 light patients This clinical trial is a double-blind trial, which has not yet been unblinded On the same day, the World Health Organization said two new crown clinical trials such as ridcivir are expected to have preliminary results within three weeks.